Andere Sprachen CS MEDICA A/S

Aktien

CSMED

DK0061668225

CSMED

Schlusskurs NORDIC GROWTH MARKET Andere Börsenplätze 00:00:00 17.05.2024			% 5 Tage	% 1. Jan.
6.007 ^DKK	-7.84%		-3.94%	+28.27%

30.04.	CS Medica A/S geht neue Partnerschaft mit einem OTC-Unternehmen ein, das eine starke Position im Segment der chronischen Schmerzen in Deutschland einnimmt	CI
22.04.	CS Medica A/S steigert seine globale Reichweite mit der 180° Drug Store-Allianz, die auf einer Pull-Markt-Strategie basiert	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

CS MEDICA A/S announces financial results for the first half of the financial year 2023/24	17.05.
CS MEDICA Aligns Financial Priorities: Transition to Calendar Year 2024 Postponed	07.05.
CS MEDICA A/S Enters New Partnership with Award-Winning OTC Company Holding a Strong Position in the Chronic Pain Segment in Germany	30.04.
CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany	30.04.
CS MEDICA A/S: CEO, Lone Henriksen, buys shares in the Company	25.04.
CS MEDICA Advances Global Reach with 180˚ Drug Store Alliance, Powered by Pull Market Strategy.	22.04.
CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy	22.04.
CS MEDICA A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	04.04.
CS Medica A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	04.04.
CS MEDICA Update: Rescheduled Q4 2023 Presentation	03.04.
Correction:CS MEDICA A/S: Publication of 2023 Q report	02.04.
CS MEDICA A/S: Release of 2023 Q report, for the period October - December 2023, including an invitation to a live-streamed conference call on 5st April, at 11 AM CET.	29.03.
CS MEDICA A/S: Minutes of the General Assembly	29.02.
Letter from the CEO: CS MEDICA's 2024 Progress Report	28.02.
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN® into Jordan	20.02.
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN into Jordan	20.02.
CS MEDICA A/S: Notice of Shareholders' Annual General Meeting	14.02.
CS MEDICA A/S: Publication of Annual Report 2022/2023	14.02.
CS Medica Obtains Danish Patent for Wound Healing Gel	02.02.
CS MEDICA A/S Achieves New Milestone with Patent on their Wound Care Treatment.	02.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen CS MEDICA A/S

Aktien

CSMED

DK0061668225

CSMED

Andere Sprachen

Filter